Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Alzheimer's Disease
Trial Information
Alzheimer's Fades Memories
To explore new ways of slowing the disease progression, we need your help.
We are conducting a research study to evaluate an investigational medication when compared to placebo (inactive substance) in patients with Alzheimer's disease.
Study participation may last up to 2 years and may include 20 visits to the study clinic. All study related office visits, medical evaluations, and investigational medication (or placebo) will be provided to qualified study participants at no cost.
You or a loved one may be eligible for participation if he or she is:
- At least 55 years of age
- Has a diagnosis of probable Alzheimer's disease
- Lives at home or in a community setting with a caregiver who has frequent contact with the patient and can also accompany the patient to study clinic visits
You or a loved one may be ineligible for participation if he or she:
- Has a serious or unstable illness
James Patterson, M.D., Ph.D., Director, Laboratory of Biological Psychiatry
Psychopharmacology Research Clinic LSUHSC-Shreveport
3202 William Avenue
Shreveport, LA 71103
Phone: 318-813-2070
Fax: 318-813-2080
EMail: brogge@lsuhsc.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
